The impact of the novel starch-lipid complexes on the glucolipids metabolism, inflammation, and gut dysbiosis of type 2 diabetes mellitus rats
It has been widely accepted that resistant starch (RS) provides numerous health benefits for human. In this research, we aimed at evaluating the performance of novel starch-lipid complexes, RS5, in comparison with RS2 on physical features, glucolipids metabolism, inflammation, and gut microbiota pro...
Saved in:
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Tsinghua University Press
2024-11-01
|
Series: | Food Science and Human Wellness |
Subjects: | |
Online Access: | https://www.sciopen.com/article/10.26599/FSHW.2023.9250008 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1841550079572312064 |
---|---|
author | Yingshuang Lu Renbing Qin Jin Wang Fengjuan Xiang Yan Zhang Bowei Zhang Dancai Fan Huan Lü Xuemeng Ji Shujun Wang Shuo Wang |
author_facet | Yingshuang Lu Renbing Qin Jin Wang Fengjuan Xiang Yan Zhang Bowei Zhang Dancai Fan Huan Lü Xuemeng Ji Shujun Wang Shuo Wang |
author_sort | Yingshuang Lu |
collection | DOAJ |
description | It has been widely accepted that resistant starch (RS) provides numerous health benefits for human. In this research, we aimed at evaluating the performance of novel starch-lipid complexes, RS5, in comparison with RS2 on physical features, glucolipids metabolism, inflammation, and gut microbiota profiles of type 2 diabetes mellitus (T2DM) rats. The T2DM model was established by streptozotocin injection to the high-fat-sugar fed rats. According to a serial of biochemical analyses, we found that RS5 diets were strongly correlated with enhanced homeostatic model assessment for insulin secretion (HOMA-IS), high-density lipoprotein cholesterol (HDL-C), adiponectin (ADP), insulin action index (IAI), glucagon-like peptide-1 (GLP1), and short-chain fatty acids (SCFAs) in T2DM rats whilst negatively associated with the low-density lipoprotein (LDL-C) and inflammatory cytokines, showing the capabilities to ameliorate T2DM symptoms by regulation of glucolipid metabolism, gut metabolites, and inflammation. On the other hand, RS2-enriched supplementations were influential in the mediation of insulin secretion to improve glucose metabolism. The increasing evidence collected herein suggested that intestinal microbiota could mediate glucolipids metabolism and alleviate inflammation after certain microflora nourished by RS. In addition, RS intake made an impact on phosphoinositide 3-kinase/protein kinase B signaling pathway that might contribute to the improvement of glucose metabolism, insulin resistance, and inflammatory responses. |
format | Article |
id | doaj-art-0bac6c866cbf4bf6a0fa40ec0c8c0932 |
institution | Kabale University |
issn | 2097-0765 2213-4530 |
language | English |
publishDate | 2024-11-01 |
publisher | Tsinghua University Press |
record_format | Article |
series | Food Science and Human Wellness |
spelling | doaj-art-0bac6c866cbf4bf6a0fa40ec0c8c09322025-01-10T06:57:02ZengTsinghua University PressFood Science and Human Wellness2097-07652213-45302024-11-011363210322310.26599/FSHW.2023.9250008The impact of the novel starch-lipid complexes on the glucolipids metabolism, inflammation, and gut dysbiosis of type 2 diabetes mellitus ratsYingshuang Lu0Renbing Qin1Jin Wang2Fengjuan Xiang3Yan Zhang4Bowei Zhang5Dancai Fan6Huan Lü7Xuemeng Ji8Shujun Wang9Shuo Wang10Tianjin Key Laboratory of Food Science and Health, School of Medicine, Nankai University, Tianjin 300071, ChinaSchool of Food Science, Henan Institute of Science and Technology, Xinxiang 453600, ChinaTianjin Key Laboratory of Food Science and Health, School of Medicine, Nankai University, Tianjin 300071, ChinaSchool of Food Science, Henan Institute of Science and Technology, Xinxiang 453600, ChinaTianjin Key Laboratory of Food Science and Health, School of Medicine, Nankai University, Tianjin 300071, ChinaTianjin Key Laboratory of Food Science and Health, School of Medicine, Nankai University, Tianjin 300071, ChinaTianjin Key Laboratory of Food Science and Health, School of Medicine, Nankai University, Tianjin 300071, ChinaTianjin Key Laboratory of Food Science and Health, School of Medicine, Nankai University, Tianjin 300071, ChinaTianjin Key Laboratory of Food Science and Health, School of Medicine, Nankai University, Tianjin 300071, ChinaState Key Laboratory of Food Nutrition and Safety, Tianjin University of Science & Technology, Tianjin 300457, ChinaTianjin Key Laboratory of Food Science and Health, School of Medicine, Nankai University, Tianjin 300071, ChinaIt has been widely accepted that resistant starch (RS) provides numerous health benefits for human. In this research, we aimed at evaluating the performance of novel starch-lipid complexes, RS5, in comparison with RS2 on physical features, glucolipids metabolism, inflammation, and gut microbiota profiles of type 2 diabetes mellitus (T2DM) rats. The T2DM model was established by streptozotocin injection to the high-fat-sugar fed rats. According to a serial of biochemical analyses, we found that RS5 diets were strongly correlated with enhanced homeostatic model assessment for insulin secretion (HOMA-IS), high-density lipoprotein cholesterol (HDL-C), adiponectin (ADP), insulin action index (IAI), glucagon-like peptide-1 (GLP1), and short-chain fatty acids (SCFAs) in T2DM rats whilst negatively associated with the low-density lipoprotein (LDL-C) and inflammatory cytokines, showing the capabilities to ameliorate T2DM symptoms by regulation of glucolipid metabolism, gut metabolites, and inflammation. On the other hand, RS2-enriched supplementations were influential in the mediation of insulin secretion to improve glucose metabolism. The increasing evidence collected herein suggested that intestinal microbiota could mediate glucolipids metabolism and alleviate inflammation after certain microflora nourished by RS. In addition, RS intake made an impact on phosphoinositide 3-kinase/protein kinase B signaling pathway that might contribute to the improvement of glucose metabolism, insulin resistance, and inflammatory responses.https://www.sciopen.com/article/10.26599/FSHW.2023.9250008resistant starchtype 2 diabetesglucolipid metabolismgut microbiotainflammation |
spellingShingle | Yingshuang Lu Renbing Qin Jin Wang Fengjuan Xiang Yan Zhang Bowei Zhang Dancai Fan Huan Lü Xuemeng Ji Shujun Wang Shuo Wang The impact of the novel starch-lipid complexes on the glucolipids metabolism, inflammation, and gut dysbiosis of type 2 diabetes mellitus rats Food Science and Human Wellness resistant starch type 2 diabetes glucolipid metabolism gut microbiota inflammation |
title | The impact of the novel starch-lipid complexes on the glucolipids metabolism, inflammation, and gut dysbiosis of type 2 diabetes mellitus rats |
title_full | The impact of the novel starch-lipid complexes on the glucolipids metabolism, inflammation, and gut dysbiosis of type 2 diabetes mellitus rats |
title_fullStr | The impact of the novel starch-lipid complexes on the glucolipids metabolism, inflammation, and gut dysbiosis of type 2 diabetes mellitus rats |
title_full_unstemmed | The impact of the novel starch-lipid complexes on the glucolipids metabolism, inflammation, and gut dysbiosis of type 2 diabetes mellitus rats |
title_short | The impact of the novel starch-lipid complexes on the glucolipids metabolism, inflammation, and gut dysbiosis of type 2 diabetes mellitus rats |
title_sort | impact of the novel starch lipid complexes on the glucolipids metabolism inflammation and gut dysbiosis of type 2 diabetes mellitus rats |
topic | resistant starch type 2 diabetes glucolipid metabolism gut microbiota inflammation |
url | https://www.sciopen.com/article/10.26599/FSHW.2023.9250008 |
work_keys_str_mv | AT yingshuanglu theimpactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats AT renbingqin theimpactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats AT jinwang theimpactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats AT fengjuanxiang theimpactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats AT yanzhang theimpactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats AT boweizhang theimpactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats AT dancaifan theimpactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats AT huanlu theimpactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats AT xuemengji theimpactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats AT shujunwang theimpactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats AT shuowang theimpactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats AT yingshuanglu impactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats AT renbingqin impactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats AT jinwang impactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats AT fengjuanxiang impactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats AT yanzhang impactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats AT boweizhang impactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats AT dancaifan impactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats AT huanlu impactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats AT xuemengji impactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats AT shujunwang impactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats AT shuowang impactofthenovelstarchlipidcomplexesontheglucolipidsmetabolisminflammationandgutdysbiosisoftype2diabetesmellitusrats |